Medicinali

Segui
Realistic illustration contrasting social stigma: neutral for overweight, positive for exercise weight loss, negative for Ozempic users.
Immagine generata dall'IA

Study finds people who use Ozempic-like drugs for weight loss face added stigma

Riportato dall'IA Immagine generata dall'IA Verificato

People who lose weight using GLP-1 medications such as Ozempic and Wegovy may be judged more negatively than those who lose weight through diet and exercise — and even more negatively than people who do not lose weight at all — according to a new study led by Rice University psychologist Erin Standen.

Il governatore di Buenos Aires, Axel Kicillof, ha annunciato un potenziamento nella distribuzione di farmaci in tutti i 135 comuni della provincia. La misura espande il programma Medicamentos Bonaerenses a seguito dei tagli nazionali al programma Remediar. Kicillof ha criticato duramente il governo nazionale per il sottofinanziamento delle politiche sanitarie.

Riportato dall'IA

Germany's Gemeinsamer Bundesausschuss (G-BA) decided on Thursday to allow health insurers to cover four drugs that alleviate certain Long Covid symptoms. Previously, patients had to pay for these off-label uses themselves. The ruling eases access for the country's 74 million statutory insurees.

The U.S. Food and Drug Administration (FDA) and the European Medicines Agency have approved lenacapavir as pre-exposure prophylaxis (PrEP) for uninfected individuals at high risk. This antiretroviral drug is administered via subcutaneous injections every six months, providing an alternative to daily pills. The World Health Organization endorses its use in comprehensive prevention strategies.

Riportato dall'IA

In chile's presidential runoff, candidates like Jeannette Jara have revived ideas to eliminate vat on drugs and end oncology waiting lists. These proposals aim to ease the high cost of medications, which accounts for 60% of out-of-pocket health spending. Experts see a chance for agreements that go beyond the election.

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta